News
Crossed
Your contact person

Jan Phillip Denkers
Manager PR & Communications
T +49.40.593 62 61-23
E-Mail

Filter reset
The excagol medtech team testing the laboratory demonstrator. (Picture: © excagol medtech)

Digitalisation, MedTech

excagol medtech achieves development milestone

Recently a laboratory demonstrator for the semi-automatic venipuncture automate was constructed, including hardware and software.
Eppendorf sells its micro manipulation product portfolio to a German subsidiary of Calibre Scientific. (Image: © Eppendorf)

Biotech & Pharma

Eppendorf divests micro manipulation product portfolio

The globally active Eppendorf Group has divested its micro manipulation product portfolio to Calibre Scientific GmbH in Hamburg, Germany. Calibre Scientific GmbH is part of the U.S.-based global life …
Artist's impression of the molecule Darobactin 22, its docking site in the cell membrane and the target bacteria. (Credit: © HIPS/HZI)

Biotech & Pharma, Research, Academia & Universities

Scientists engineer new potent antibiotic

In the constant arms race with bacteria, scientists at the Centre for Structural Systems Biology CSSB together with colleagues from the Helmholtz Institute for Pharmaceutical Research Saarland HIPS …
Tumor Cells (Image: © osteolabs)

Biotech & Pharma, Forschung & Hochschulen 

Osteolabs technology can detect bone metastases early

So far osteolabs has successfully applied its proprietary Calcium Isotope Marker Technology for the early detection and therapy monitoring in the field of osteoporosis with more than 3,500 patient …

Crown Bioscience to Acquire Indivumed’s Service Business

Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, has announced it has entered into an agreement to acquire the IndivuServ business unit of Indivumed …
Together with colleagues, Dr Sophie Steinhäuser was able to describe a previously unknown mechanism for AML with IDH1 mutation, which causes a faulty spatial arrangement of the DNA structure and thus leading to the activation of a specific cancer-promoting gene. (Photo: © Kathrin Richter, UKSH)

Research, Academia & Universities

New insights into the genetic basis of leukemia

Acute myeloid leukemia (AML) is a malignant disease of the haematopoietic system that originates from immature precursors of red blood cells, platelets and part of the white blood cells. While in …

Biotech & Pharma, LSN

LSN e.V. introduces: TIEFENBACHER GROUP

100% family owned since 1963, TIEFENBACHER GROUP is an international healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From initial idea to market …
In all 11 doctoral candidates will work together to advance our understanding of microbial and biogeochemical processes in a range of glacial ecosystems, the exchanges between them and the surrounding ecosystems. (Graphics © ICEBIO)

Research, Academia & Universities

New research project: ICEBIO

ICEBIO is a PhD network that will train the next generation of experts in glacier microbiology and biogeochemistry.
Building Bridges: The project’s work packages are Cross-Border Innovation and Research, Hanseatic Science Cloud, and Strengthening the Regional Life Science Ecosystem. (Photo: © Fredrik Olsson/Øresundsbron)

Funding & Competition, LSN

HALRIC consortium received EU funding

Southern Scandinavia and Northern Germany form a leading life science region with unique research infrastructures that can help transform research into innovation. There is especially a large unused …
The iSenseDNA team at the kick-off meeting in October at the University of Padua (Italy). (Photo: © Univ. Uppsala)

Biotech & Pharma, Research, Academia & Universities

Large-scale project iSenseDNA launched

Understanding how a specific molecule behaves during complex biological processes is a challenge facing biomedical research, despite major biotechnological progress made in recent years. A major new …
In September 2022, Hans-Åke Fabricius presented the company CELL RECEPTOR and the developed method at the LSN event "Ins Netz gegangen".

Biotech & Pharma, LSN

Welcome to LSN e.V.: CELL RECEPTOR

Today, cancer treatment primarily involves the use of toxic agents, highly cell-damaging physical agents such as radiation, or other severe procedures. Undesirable and sometimes serious side effects …

Research, Academia & Universities

Molecular water research for life

Water is key to life on our planet and plays a central role in human cells, clouds in the atmosphere, water-based catalysts in industry, and many other important systems.